Survey on the assessment and use of aspirin for pre-eclampsia risk in the UK
Please consider completing this brief survey. We are interested in optimising the use and efficacy of aspirin therapy for the prevention of pre-term pre-eclampsia. We would like to understand current UK practice to identify potential areas for improvement. This work has received ethical approval from the University of Sheffield Research Ethics Committee. Completion of the form will be taken as consent to use the information provided for research purposes, including presentation or publication of collated data in relevant settings.. No personal identifiable information is requested as part of this form. 

If you wish to raise an issue about this work please contact the investigators (Dr Victoria Parker v.parker@sheffield.ac.uk) or you wish to make a complaint about the conduct of this work please contact Professor Stephen Renshaw, Head of the Division of Clinical Medicine, University of Sheffield (clinmed-hod@sheffield.ac.uk).

Thank you for your valuable time. Dr Victoria Parker, Clinical Lecturer in O+G and Dr William Parker, Clinical Lecturer in Cardiology, University of Sheffield.



Sign in to Google to save your progress. Learn more
Where is your practice predominantly based?
Clear selection
Which best describes your clinical role?
Clear selection
How long have you been a Consultant for? (years)
Clear selection
Which risk score do you use most frequently to assess risk of pre-eclampsia?
Clear selection
If you use a score,  how useful do you find it?
Not at all useful
Extremely useful
Clear selection
If you use a score, what is your perception of how useful pregnant women find the score?
Not at all useful
Extremely useful
Clear selection
In your assessment of pre-eclamptic risk, do you routinely measure PAPP-A?
Clear selection
To which risk categories of pregnant women do you prescribe aspirin for prevention of pre-eclampsia? (Select all that apply)
Clear selection
At what gestational age do you aim to commence aspirin therapy?
Clear selection
If you provide prophylactic aspirin, what dose and regimen do you prescribe?
Clear selection
Do you ever adjust the dose of aspirin for clinical characteristics such as weight or BMI?
Clear selection
At what gestational age would you usually stop aspirin if prescribed for prevention of pre-eclampsia?
Clear selection
Where you recommend it, how often do you feel you can successfully convince women to start aspirin where indicated?
Clear selection
In general, how good do you think compliance is with aspirin therapy is when recommended in pregnancy?
Clear selection
What do you feel are barriers to women complying with the recommendation to take aspirin?
Not a barrier at all
Sometimes a barrier
Often a barrier
Always a barrier
Don't know
Reluctance to take medication during pregnancy
Reluctance to take medication in general (not specific to pregnancy)
Lack of understanding around indication
Side effects
Logistics of obtaining supply
Clear selection
How much do you worry about bleeding risk in pregnant women taking aspirin?
Clear selection
If you have any other comments to make on this topic we would be pleased to receive them below...
Thank you for your time
Submit
Clear form
Never submit passwords through Google Forms.
This form was created inside of University of Sheffield. Report Abuse
Google Forms